Soybean Oil Intravenous Lipid Emulsion Suppliers & Bulk Manufacturers

Available Forms: Infusion

Available Strengths: 10%, 20%, 30%

Reference Brands: Intralipid (UK)

Category: Parenteral Nutrition

Soybean oil intravenous lipid emulsion is available in Infusion and strengths such as 10%, 20%, 30%. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Soybean oil intravenous lipid emulsion is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Soybean oil intravenous lipid emulsion can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Intralipids are intravenous lipid emulsions that have been explored as an adjunct therapy in reproductive medicine, particularly in women with recurrent pregnancy loss. Emerging evidence suggests that intralipid infusion may help suppress elevated uterine natural killer (uNK) cell activity, which is believed to play a role in implantation failure and early pregnancy loss in certain patients. By modulating immune responses within the uterine environment, intralipids may create more favorable conditions for embryo implantation and ongoing pregnancy.

Clinical interest in this approach has grown following case observations where women with a history of recurrent pregnancy loss and increased uterine natural killer cell activity achieved successful pregnancies after receiving intralipid therapy. Although the exact mechanism of action is not fully understood, the immunomodulatory properties of lipid emulsions are thought to contribute to improved reproductive outcomes in selected cases.

Routine assessment of uterine natural killer cell activity may help identify patients who could potentially benefit from this therapy. However, further controlled studies and research on newer intravenous lipid emulsions are recommended to better define their role, efficacy, and safety in fertility treatment protocols.